Florbetazine not checked

HTA Co., Ltd.

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 3 trial completes
Trials
1 active
2 in total

What this is

How it works
How it works isn't classified yet
How it’s given
“normal cognitive function, mild cognitive impairment (MCI) caused by Alzheimer's disease (AD) using \[18F\]Fluorbetazine injection.”In the company’s words, NCT07764679 on ClinicalTrials.gov
Tested for
Mild Cognitive Impairment (MCI), Alzheimer's Disease (AD)
Main trialPhase 3
“A multicenter phase III clinical study evaluating the diagnostic performance and safety of PET for the deposition of Aβ plaques in the brain of participants with normal cognitive function, MCI and AD using \[18F\]Fluorbetazine injection.”In the company’s words, NCT07764679 on ClinicalTrials.gov
Other names
Fluorbetazine

Other drugs for Mild Cognitive Impairment (MCI)

All 25 drugs for Mild Cognitive Impairment (MCI)

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials2

TrialPhaseCompletesWhat it tests
Phase 3Recruiting 31 Dec 2027 A Clinical Study Evaluating the Diagnostic Performance and Safety of PET for the Deposition of Aβ Plaques in the Brain of Participants With Normal Cognitive Function, MCI and AD Using [18F]Fluorbetazine Injection
Phase 1Completed 30 Jun 2025 A Phase I Clinical Study on the Safety and Pharmacokinetics of [18F]Florbetazine Injection
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Florbetazine

Following is part of Solo: you see every change to Florbetazine the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in